Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

419 trials

NCT07803809
Recruiting
Phase 1 Clinical Study of MWN105 Injection in Participants With Overweight or Obesity
Phase 1 · China · 1 site
Registry update: 8 Sept 2026
NCT07492992
Recruiting
HOME-AHCL: Home-Based Implementation of an Advanced Hybrid Closed-Loop System With Telemonitoring in Type 1 Diabetes
Not applicable · Spain · 3 sites
Registry update: 29 Sept 2026
NCT07567170
Recruiting
Satisfaction of Specific Modes Related to Physical Activity in People Living With Type 1 Diabetes and Using an Hybrid Closed-loop System
Not applicable · France · 1 site
Registry update: 5 May 2026
2025-524679-22-00
Recruiting
Up-titration of sulfonylurea (SU) in individuals with HNF1A- and HNF4A-MODY – A Steno MODERN-MODY project (MM-SUUP)
Phase 2 · Denmark · 2 sites
Registry update: 4 Mar 2026
NCT07479329
Recruiting
Estimated Risk of Preeclampsia in the First Trimester and Its Association With Subclinical Atherosclerosis and Cardiovascular Risk in Women With Type 1 Diabetes
Not applicable · Spain · 2 sites
Registry update: 5 Nov 2026
NCT06964087
Recruiting
Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus
Phase 2 · United States · 5 sites
Registry update: 6 Apr 2026
2025-523996-45-00
Recruiting
The POST-PRANDIAL HYPO-AVOID STUDY Low-Dose Glucagon and Automated Insulin Delivery for Prevention of Spontaneous Exercise-Induced Hypoglycemia in People with Type 1 Diabetes
Phase 4 · Denmark · 1 site
Registry update: 16 Mar 2026
NCT07830082
Recruiting
Drawing and Writing Activities in Adolescents With Type 1 Diabetes
Not applicable · 1 site
Registry update: 21 Sept 2026
NCT07490964
Recruiting
Polycystic Ovary Syndrome in Type 1 Diabetes
Not applicable · Spain · 1 site
Registry update: 3 Sept 2026
NCT07528105
Recruiting
Allogeneic Anti-CD7 CAR-T for Type 1 Diabetes
Early phase 1 · China · 1 site
Registry update: 14 Apr 2026
NCT07676565
Recruiting
Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study
Not applicable · United States · 17 sites
Registry update: 16 Oct 2026
NCT07360080
Recruiting
Long-Term Outcomes of Teplizumab in Routine Clinical Care
Not applicable · United Arab Emirates, Germany, Israel, United States · 12 sites
Registry update: 9 Nov 2026
NCT07317102
Recruiting
Omnipod-5 A French Prospective Multicentric Study in Real World (Optimal-B)
Not applicable · France · 24 sites
Registry update: 3 Aug 2026
NCT07457580
Recruiting
Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs)
Not applicable · Belgium, Germany, Spain, France, United Kingdom, Italy · 16 sites
Registry update: 9 Nov 2026
NCT07498738
Recruiting
Making Diabetes Care Fit for Young Adults Living With Type 1 Diabetes: Observations, Reflections and Expert Opinions
Not applicable · Netherlands · 2 sites
Registry update: 2 Sept 2026
NCT07910721
Recruiting
Continuous Monitoring of Plantar Temperature Variations Using Connected Insoles and a Mobile Application for Diabetic Foot.
Not applicable · France · 3 sites
Registry update: 2 Nov 2026
NCT07061574
Recruiting
A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
Phase 1/2 · United States · 11 sites
Registry update: 16 Oct 2026
NCT07416656
Recruiting
Validation of Hemoglobin A1c in Patients With Inflammatory Arthritis Treated With Sulfasalazine
Not applicable · Denmark · 1 site
Registry update: 25 Jun 2026
NCT07211126
Recruiting
The Real-World Control-IQ Glycemic Control and Quality of Life Study in Type 1 Diabetes in France
Not applicable · France · 25 sites
Registry update: 14 Oct 2026
NCT07293715
Recruiting
Permissive Versus Strict Intrapartum Glucose Management in Type 1 and Type 2 Diabetes (PRISM)
Phase 4 · United States · 1 site
Registry update: 9 Nov 2026

Ordered by registry start date. Freshness and sponsorship never change the order.